1. Home
  2. IZM vs MBAI Comparison

IZM vs MBAI Comparison

Compare IZM & MBAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ICZOOM Group Inc.

IZM

ICZOOM Group Inc.

HOLD

Current Price

$0.48

Market Cap

12.3M

ML Signal

HOLD

Logo Check-Cap Ltd. Ordinary Share

MBAI

Check-Cap Ltd. Ordinary Share

N/A

Current Price

$1.63

Market Cap

12.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
IZM
MBAI
Founded
2011
2004
Country
China
Israel
Employees
N/A
85
Industry
Consumer Electronics/Video Chains
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
12.3M
12.0M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
IZM
MBAI
Price
$0.48
$1.63
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
3.9M
46.6K
Earning Date
10-24-2025
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$10.39
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.37
$1.31
52 Week High
$2.74
$3.92

Technical Indicators

Market Signals
Indicator
IZM
MBAI
Relative Strength Index (RSI) 40.92 49.29
Support Level $0.37 $1.38
Resistance Level $2.69 $1.89
Average True Range (ATR) 0.13 0.16
MACD 0.02 0.01
Stochastic Oscillator 16.15 29.28

Price Performance

Historical Comparison
IZM
MBAI

About IZM ICZOOM Group Inc.

ICZOOM Group Inc. operates an e-commerce platform selling electronic components to SMEs in China across consumer electronics, IoT, automotive, and industrial control sectors. It offers two main product categories: semiconductor products, including integrated circuits and optoelectronics, and electronic equipment and tools such as electromechanical and MRO supplies. The company also provides services like customs clearance, temporary warehousing, and logistics, earning additional commission fees. The majority of its revenue comes from electronic component sales.

About MBAI Check-Cap Ltd. Ordinary Share

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.

Share on Social Networks: